Recombinant Mouse Osteoprotegerin/TNFRSF11B Fc Chimera, CF

• Supplier: R&D Systems
• Catalog: 459-MO-100
• Category: Protein
• Nature: Recombinant
• Source: Mouse myeloma cell line, NS0-derived
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• SwissProt/Accession: Q6PI12
• Gene: TNFRSF11B

Product References

SH3BP2 cherubism mutation potentiates TNF-alpha-induced osteoclastogenesis via - SH3BP2 cherubism mutation potentiates TNF-alpha-induced osteoclastogenesis via

Mukai T, Ishida S, Ishikawa R, Yoshitaka T, Kittaka M, Gallant R, Lin YL, Rottapel R, Brotto M, Reichenberger EJ, Ueki Y. J Bone Miner Res. 2014 Dec;29(12):2618-35.

An inducible, ligand-independent receptor activator of NF-kappaB gene to control - An inducible, ligand-independent receptor activator of NF-kappaB gene to control

Rementer CW, Wu M, Buranaphatthana W, Yang HY, Scatena M, Giachelli CM. PLoS One. 2013 Dec 27;8(12):e84465.

Receptor activator of nuclear factor kappaB ligand (RANKL) protein expression by - Receptor activator of nuclear factor kappaB ligand (RANKL) protein expression by

Onal M, Xiong J, Chen X, Thostenson JD, Almeida M, Manolagas SC, O'Brien CA. J Biol Chem. 2012 Aug 24;287(35):29851-60.

Inflammatory arthritis increases mouse osteoclast precursors with myeloid - Inflammatory arthritis increases mouse osteoclast precursors with myeloid

Charles JF, Hsu LY, Niemi EC, Weiss A, Aliprantis AO, Nakamura MC. J Clin Invest. 2012 Dec;122(12):4592-605.

Osteoprotegerin reduces the serum level of receptor activator of NF-kappaB ligand - Osteoprotegerin reduces the serum level of receptor activator of NF-kappaB ligand

Nakamichi Y, Udagawa N, Kobayashi Y, Nakamura M, Yamamoto Y, Yamashita T, Mizoguchi T, Sato M, Mogi M, Penninger JM, Takahashi N. J Immunol. 2007 Jan 1;178(1):192-200.

Cytokine-induced osteoprotegerin expression protects pancreatic beta cells - Cytokine-induced osteoprotegerin expression protects pancreatic beta cells

Schrader J, Rennekamp W, Niebergall U, Schoppet M, Jahr H, Brendel MD, Horsch D, Hofbauer LC. Diabetologia. 2007 Jun;50(6):1243-7. Epub 2007 Apr 19.

Serotonin and fluoxetine modulate bone cell function in vitro. - Serotonin and fluoxetine modulate bone cell function in vitro.

Gustafsson BI, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum HL, Slordahl K, Tamburstuen MV, Reseland JE, Syversen U. J Cell Biochem. 2006 May 1;98(1):139-51.

JunB as a downstream mediator of PTHrP actions in cementoblasts. - JunB as a downstream mediator of PTHrP actions in cementoblasts.

Berry JE, Ealba EL, Pettway GJ, Datta NS, Swanson EC, Somerman MJ, McCauley LK. J Bone Miner Res. 2006 Feb;21(2):246-57. Epub 2005 Nov 7.

17beta-estradiol (E2) modulates cytokine and chemokine expression in human - 17beta-estradiol (E2) modulates cytokine and chemokine expression in human

Bengtsson AK, Ryan EJ, Giordano D, Magaletti DM, Clark EA. Blood. 2004 Sep 1;104(5):1404-10. Epub 2004 May 13.

Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 - Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6

Cao J, Venton L, Sakata T, Halloran BP. J Bone Miner Res. 2003 Feb;18(2):270-7.